Titre : Leucémies

Leucémies : Questions médicales fréquentes

Termes MeSH sélectionnés :

Polycyclic Compounds
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Leucémies : Questions médicales les plus fréquentes", "headline": "Leucémies : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Leucémies : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-29", "dateModified": "2025-04-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Leucémies" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs par type histologique", "url": "https://questionsmedicales.fr/mesh/D009370", "about": { "@type": "MedicalCondition", "name": "Tumeurs par type histologique", "code": { "@type": "MedicalCode", "code": "D009370", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Leucémie myéloïde", "alternateName": "Leukemia, Myeloid", "url": "https://questionsmedicales.fr/mesh/D007951", "about": { "@type": "MedicalCondition", "name": "Leucémie myéloïde", "code": { "@type": "MedicalCode", "code": "D007951", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Leucémie aigüe myéloïde", "alternateName": "Leukemia, Myeloid, Acute", "url": "https://questionsmedicales.fr/mesh/D015470", "about": { "@type": "MedicalCondition", "name": "Leucémie aigüe myéloïde", "code": { "@type": "MedicalCode", "code": "D015470", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539.275" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Leucémie aiguë à basophiles", "alternateName": "Leukemia, Basophilic, Acute", "url": "https://questionsmedicales.fr/mesh/D015471", "about": { "@type": "MedicalCondition", "name": "Leucémie aiguë à basophiles", "code": { "@type": "MedicalCode", "code": "D015471", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539.275.125" } } }, { "@type": "MedicalWebPage", "name": "Leucémie aigüe à éosinophiles", "alternateName": "Leukemia, Eosinophilic, Acute", "url": "https://questionsmedicales.fr/mesh/D015472", "about": { "@type": "MedicalCondition", "name": "Leucémie aigüe à éosinophiles", "code": { "@type": "MedicalCode", "code": "D015472", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539.275.300" } } }, { "@type": "MedicalWebPage", "name": "Leucémie aigüe mégacaryoblastique", "alternateName": "Leukemia, Megakaryoblastic, Acute", "url": "https://questionsmedicales.fr/mesh/D007947", "about": { "@type": "MedicalCondition", "name": "Leucémie aigüe mégacaryoblastique", "code": { "@type": "MedicalCode", "code": "D007947", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539.275.450" } } }, { "@type": "MedicalWebPage", "name": "Leucémie aigüe monoblastique", "alternateName": "Leukemia, Monocytic, Acute", "url": "https://questionsmedicales.fr/mesh/D007948", "about": { "@type": "MedicalCondition", "name": "Leucémie aigüe monoblastique", "code": { "@type": "MedicalCode", "code": "D007948", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539.275.484" } } }, { "@type": "MedicalWebPage", "name": "Leucémie aiguë promyélocytaire", "alternateName": "Leukemia, Promyelocytic, Acute", "url": "https://questionsmedicales.fr/mesh/D015473", "about": { "@type": "MedicalCondition", "name": "Leucémie aiguë promyélocytaire", "code": { "@type": "MedicalCode", "code": "D015473", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539.275.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Leucémie aiguë à basophiles", "alternateName": "Leukemia, Basophilic, Acute", "url": "https://questionsmedicales.fr/mesh/D015471", "about": { "@type": "MedicalCondition", "name": "Leucémie aiguë à basophiles", "code": { "@type": "MedicalCode", "code": "D015471", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539.275.125" } } }, { "@type": "MedicalWebPage", "name": "Leucémie aigüe à éosinophiles", "alternateName": "Leukemia, Eosinophilic, Acute", "url": "https://questionsmedicales.fr/mesh/D015472", "about": { "@type": "MedicalCondition", "name": "Leucémie aigüe à éosinophiles", "code": { "@type": "MedicalCode", "code": "D015472", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539.275.300" } } }, { "@type": "MedicalWebPage", "name": "Leucémie aigüe mégacaryoblastique", "alternateName": "Leukemia, Megakaryoblastic, Acute", "url": "https://questionsmedicales.fr/mesh/D007947", "about": { "@type": "MedicalCondition", "name": "Leucémie aigüe mégacaryoblastique", "code": { "@type": "MedicalCode", "code": "D007947", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539.275.450" } } }, { "@type": "MedicalWebPage", "name": "Leucémie aigüe monoblastique", "alternateName": "Leukemia, Monocytic, Acute", "url": "https://questionsmedicales.fr/mesh/D007948", "about": { "@type": "MedicalCondition", "name": "Leucémie aigüe monoblastique", "code": { "@type": "MedicalCode", "code": "D007948", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539.275.484" } } }, { "@type": "MedicalWebPage", "name": "Leucémie aiguë promyélocytaire", "alternateName": "Leukemia, Promyelocytic, Acute", "url": "https://questionsmedicales.fr/mesh/D015473", "about": { "@type": "MedicalCondition", "name": "Leucémie aiguë promyélocytaire", "code": { "@type": "MedicalCode", "code": "D015473", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539.275.700" } } }, { "@type": "MedicalWebPage", "name": "Leucémie aigüe myélomonocytaire", "alternateName": "Leukemia, Myelomonocytic, Acute", "url": "https://questionsmedicales.fr/mesh/D015479", "about": { "@type": "MedicalCondition", "name": "Leucémie aigüe myélomonocytaire", "code": { "@type": "MedicalCode", "code": "D015479", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.337.539.520" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Leucémies", "alternateName": "Leukemia", "code": { "@type": "MedicalCode", "code": "D007938", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Kumaran Mudaliar", "url": "https://questionsmedicales.fr/author/Kumaran%20Mudaliar", "affiliation": { "@type": "Organization", "name": "Department of Pathology and Laboratory Medicine Loyola University Medical Center Maywood Illinois USA." } }, { "@type": "Person", "name": "Gregor Eisenwort", "url": "https://questionsmedicales.fr/author/Gregor%20Eisenwort", "affiliation": { "@type": "Organization", "name": "Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria." } }, { "@type": "Person", "name": "Irina Sadovnik", "url": "https://questionsmedicales.fr/author/Irina%20Sadovnik", "affiliation": { "@type": "Organization", "name": "Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria." } }, { "@type": "Person", "name": "Alexandra Keller", "url": "https://questionsmedicales.fr/author/Alexandra%20Keller", "affiliation": { "@type": "Organization", "name": "Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria." } }, { "@type": "Person", "name": "Daniela Berger", "url": "https://questionsmedicales.fr/author/Daniela%20Berger", "affiliation": { "@type": "Organization", "name": "Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Rh(III)-Catalyzed C-H Annulation of Alkenyl- or Arylimidazoles and (Hetero)cyclic 1,3-Dicarbonyl Compounds: A Rapid Access to Imidazo-Fused Polycyclic Compounds.", "datePublished": "2022-06-07", "url": "https://questionsmedicales.fr/article/35671457", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.orglett.2c01315" } }, { "@type": "ScholarlyArticle", "name": "Dissolved polycyclic aromatic compounds in Canada's Athabasca River in relation to Oil Sands from 2013 through 2019.", "datePublished": "2023-10-21", "url": "https://questionsmedicales.fr/article/37864721", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10661-023-11846-x" } }, { "@type": "ScholarlyArticle", "name": "QSPR Modeling and Experimental Determination of the Antioxidant Activity of Some Polycyclic Compounds in the Radical-Chain Oxidation Reaction of Organic Substrates.", "datePublished": "2022-10-02", "url": "https://questionsmedicales.fr/article/36235050", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/molecules27196511" } }, { "@type": "ScholarlyArticle", "name": "Atmospheric emissions estimation of polycyclic aromatic compounds from an oil sands tailings pond using passive air samplers.", "datePublished": "2023-10-13", "url": "https://questionsmedicales.fr/article/37839749", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.chemosphere.2023.140423" } }, { "@type": "ScholarlyArticle", "name": "Extensive chemical and bioassay analysis of polycyclic aromatic compounds in a creosote-contaminated superfund soil following steam enhanced extraction.", "datePublished": "2022-08-23", "url": "https://questionsmedicales.fr/article/36007793", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.envpol.2022.120014" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Tumeurs", "item": "https://questionsmedicales.fr/mesh/D009369" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs par type histologique", "item": "https://questionsmedicales.fr/mesh/D009370" }, { "@type": "ListItem", "position": 4, "name": "Leucémies", "item": "https://questionsmedicales.fr/mesh/D007938" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Leucémies - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Leucémies", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Leucémies", "description": "Comment diagnostique-t-on une leucémie ?\nQuels tests sont utilisés pour confirmer une leucémie ?\nQuels signes indiquent une leucémie lors des tests ?\nLes examens d'imagerie sont-ils nécessaires ?\nQuelle est l'importance de la biopsie médullaire ?", "url": "https://questionsmedicales.fr/mesh/D007938?mesh_terms=Polycyclic+Compounds&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Leucémies", "description": "Quels sont les symptômes courants de la leucémie ?\nLa perte de poids est-elle un symptôme de leucémie ?\nComment la leucémie affecte-t-elle le système immunitaire ?\nLes douleurs osseuses sont-elles liées à la leucémie ?\nLes sueurs nocturnes sont-elles un symptôme ?", "url": "https://questionsmedicales.fr/mesh/D007938?mesh_terms=Polycyclic+Compounds&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Leucémies", "description": "Peut-on prévenir la leucémie ?\nQuels facteurs de risque sont associés à la leucémie ?\nLe tabagisme augmente-t-il le risque de leucémie ?\nLes infections virales peuvent-elles causer la leucémie ?\nL'alimentation joue-t-elle un rôle dans la prévention ?", "url": "https://questionsmedicales.fr/mesh/D007938?mesh_terms=Polycyclic+Compounds&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Leucémies", "description": "Quels sont les traitements principaux de la leucémie ?\nLa chimiothérapie est-elle efficace contre toutes les leucémies ?\nQu'est-ce qu'une greffe de moelle osseuse ?\nQuels sont les effets secondaires de la chimiothérapie ?\nLa radiothérapie est-elle utilisée pour traiter la leucémie ?", "url": "https://questionsmedicales.fr/mesh/D007938?mesh_terms=Polycyclic+Compounds&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Leucémies", "description": "Quelles sont les complications possibles de la leucémie ?\nComment la leucémie affecte-t-elle la coagulation sanguine ?\nLes leucémies peuvent-elles entraîner des problèmes cardiaques ?\nQuelles infections sont fréquentes chez les patients leucémiques ?\nLes leucémies peuvent-elles causer des douleurs chroniques ?", "url": "https://questionsmedicales.fr/mesh/D007938?mesh_terms=Polycyclic+Compounds&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Leucémies", "description": "Quels sont les principaux facteurs de risque de leucémie ?\nL'âge influence-t-il le risque de leucémie ?\nLes troubles génétiques augmentent-ils le risque ?\nLe sexe joue-t-il un rôle dans le risque de leucémie ?\nLes antécédents de chimiothérapie augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D007938?mesh_terms=Polycyclic+Compounds&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une leucémie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des analyses sanguines, une biopsie de moelle osseuse et des examens d'imagerie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer une leucémie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'hémogramme, la cytométrie en flux et les tests génétiques." } }, { "@type": "Question", "name": "Quels signes indiquent une leucémie lors des tests ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une augmentation des globules blancs, une anémie et des plaquettes basses peuvent indiquer une leucémie." } }, { "@type": "Question", "name": "Les examens d'imagerie sont-ils nécessaires ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens comme la radiographie ou l'IRM peuvent aider à évaluer l'extension de la maladie." } }, { "@type": "Question", "name": "Quelle est l'importance de la biopsie médullaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La biopsie médullaire permet d'évaluer la présence de cellules leucémiques dans la moelle osseuse." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la leucémie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, fièvre, infections fréquentes et saignements faciles." } }, { "@type": "Question", "name": "La perte de poids est-elle un symptôme de leucémie ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une perte de poids inexpliquée peut être un symptôme de leucémie." } }, { "@type": "Question", "name": "Comment la leucémie affecte-t-elle le système immunitaire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "La leucémie affaiblit le système immunitaire, rendant le corps plus vulnérable aux infections." } }, { "@type": "Question", "name": "Les douleurs osseuses sont-elles liées à la leucémie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs osseuses peuvent survenir en raison de l'accumulation de cellules leucémiques." } }, { "@type": "Question", "name": "Les sueurs nocturnes sont-elles un symptôme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les sueurs nocturnes peuvent être un symptôme courant chez les patients leucémiques." } }, { "@type": "Question", "name": "Peut-on prévenir la leucémie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention garantie, mais éviter les facteurs de risque peut aider." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés à la leucémie ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'exposition aux radiations, certains produits chimiques et des maladies génétiques." } }, { "@type": "Question", "name": "Le tabagisme augmente-t-il le risque de leucémie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque connu pour certains types de leucémie." } }, { "@type": "Question", "name": "Les infections virales peuvent-elles causer la leucémie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales, comme le virus d'Epstein-Barr, sont liées à un risque accru de leucémie." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut contribuer à la santé générale, mais ne prévient pas spécifiquement la leucémie." } }, { "@type": "Question", "name": "Quels sont les traitements principaux de la leucémie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chimiothérapie, la radiothérapie et la greffe de moelle osseuse." } }, { "@type": "Question", "name": "La chimiothérapie est-elle efficace contre toutes les leucémies ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chimiothérapie est efficace pour de nombreux types de leucémie, mais pas tous." } }, { "@type": "Question", "name": "Qu'est-ce qu'une greffe de moelle osseuse ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "C'est un traitement qui remplace la moelle osseuse malade par des cellules souches saines." } }, { "@type": "Question", "name": "Quels sont les effets secondaires de la chimiothérapie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent nausées, fatigue, perte de cheveux et infections." } }, { "@type": "Question", "name": "La radiothérapie est-elle utilisée pour traiter la leucémie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la radiothérapie peut être utilisée pour traiter certaines leucémies, surtout en cas de complications." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la leucémie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent infections graves, saignements, et complications liées aux traitements." } }, { "@type": "Question", "name": "Comment la leucémie affecte-t-elle la coagulation sanguine ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La leucémie peut entraîner des troubles de la coagulation, augmentant le risque de saignements." } }, { "@type": "Question", "name": "Les leucémies peuvent-elles entraîner des problèmes cardiaques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains traitements de la leucémie peuvent augmenter le risque de problèmes cardiaques." } }, { "@type": "Question", "name": "Quelles infections sont fréquentes chez les patients leucémiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les infections bactériennes et fongiques sont courantes en raison d'un système immunitaire affaibli." } }, { "@type": "Question", "name": "Les leucémies peuvent-elles causer des douleurs chroniques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les douleurs chroniques peuvent survenir en raison de la maladie ou des traitements." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque de leucémie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent l'exposition aux radiations, certains produits chimiques et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de leucémie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de leucémie augmente avec l'âge, surtout après 60 ans." } }, { "@type": "Question", "name": "Les troubles génétiques augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles comme le syndrome de Down augmentent le risque de leucémie." } }, { "@type": "Question", "name": "Le sexe joue-t-il un rôle dans le risque de leucémie ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les hommes ont généralement un risque plus élevé de leucémie que les femmes." } }, { "@type": "Question", "name": "Les antécédents de chimiothérapie augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir reçu une chimiothérapie pour un autre cancer peut augmenter le risque de leucémie." } } ] } ] }

Sources (10000 au total)

Dissolved polycyclic aromatic compounds in Canada's Athabasca River in relation to Oil Sands from 2013 through 2019.

The Canada-Alberta Oil Sands Monitoring (OSM) Program began long-term surface water quality monitoring on the lower Athabasca River in 2012. Sampling of low level, bio-accumulative polycyclic aromatic...

QSPR Modeling and Experimental Determination of the Antioxidant Activity of Some Polycyclic Compounds in the Radical-Chain Oxidation Reaction of Organic Substrates.

The present work addresses the quantitative structure−antioxidant activity relationship in a series of 148 sulfur-containing alkylphenols, natural phenols, chromane, betulonic and betulinic acids, and...

Extensive chemical and bioassay analysis of polycyclic aromatic compounds in a creosote-contaminated superfund soil following steam enhanced extraction.

Polycyclic aromatic compounds (PACs) are organic compounds commonly found in contaminated soil. Previous studies have shown the removal of polycyclic aromatic hydrocarbons (PAHs) in creosote-contamina...

Occurrence of polycyclic aromatic compounds and potentially toxic elements contamination and corresponding interdomain microbial community assembly in soil of an abandoned gas station.

Bacteria, archaea and fungi usually coexist in various soil habitats and play important roles in biogeochemical cycle and remediation of contamination. Despite their significance, their combined bioas...

Spatial distribution, sources identification, and health risk assessment polycyclic aromatic hydrocarbon compounds and polychlorinated biphenyl compounds in total suspended particulates (TSP) in the air of South Pars Industrial region-Iran.

South Pars Industrial Energy Zone, located in the southwest of Iran along the Persian Gulf coast, encompasses many industrial units in the vicinity of urban areas. This research study investigated the...

Polycyclic aromatic compounds (PACs) in industrial soils from northwestern of China: occurrence, distribution, exposure risk, and implications on risk-based controls.

Some Polycyclic Aromatic Compounds (PACs) such as nitrated-PAHs (NPAHs), oxygenated-PAHs (OPAHs) and methyl-PAHs (MPAHs) have attracted significant concern due to derivatives have greater potential to...

A yearlong monitoring campaign of polycyclic aromatic compounds and other air pollutants at three sites in Sweden: Source identification, in vitro toxicity and human health risk assessment.

Air pollution is a complex mixture of gases and particulate matter (PM) with local and non-local emission sources, resulting in spatiotemporal variability in concentrations and composition, and thus a...